[Beta-blockaders and cardiovascular treatment: facts and theories. Part II. Therapeutic indications: ischemic heart disease and arrhythmia; limitations; conclusions]
- PMID: 25219
[Beta-blockaders and cardiovascular treatment: facts and theories. Part II. Therapeutic indications: ischemic heart disease and arrhythmia; limitations; conclusions]
Similar articles
-
[Beta-adrenergic inhibitors and coronary insufficiency].Therapie. 1985 Nov-Dec;40(6):393-6. Therapie. 1985. PMID: 2868533 French. No abstract available.
-
[The beta-blockers in coronary disease].Rev Prat. 1984 Apr 1;34(19):953-64. Rev Prat. 1984. PMID: 6144162 French. No abstract available.
-
[Beta-blockaders and cardiovascular therapy: facts and theories. Part I. Introduction, characterization; therapeutic indications: arterial hypertension].G Ital Cardiol. 1978;8(2):218-31. G Ital Cardiol. 1978. PMID: 25821 Italian. No abstract available.
-
[Beta-adrenergic receptor blockers in clinical practice].Orv Hetil. 2004 Sep 19;145(38):1951-60. Orv Hetil. 2004. PMID: 15535106 Review. Hungarian.
-
[Choice of beta-blocking agents].Duodecim. 1986;102(22):1642-50. Duodecim. 1986. PMID: 2879719 Review. Finnish. No abstract available.
Cited by
-
Hemodynamic effects of somatostatin in insulin-dependent diabetic subjects.Acta Diabetol Lat. 1979 Oct-Dec;16(4):331-7. doi: 10.1007/BF02587654. Acta Diabetol Lat. 1979. PMID: 45064 Clinical Trial.